(Q40727856)

23 September 2017

title

Exploiting human genetic variation in drug discovery and development (English)

1 reference

23 September 2017

1 reference

1 reference

E C. Jazwinska

1

1 reference

23 September 2017

publication date

1 February 2001

1 reference

23 September 2017

1 reference

23 September 2017

volume

6

1 reference

23 September 2017

issue

4

1 reference

23 September 2017

page(s)

198-205

1 reference

Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901642-1

7 January 2021

Human genome. Finally, the book of life and instructions for navigating it.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901642-1

7 January 2021

"Working draft" of human genome completed

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901642-1

7 January 2021

More than 1,000 putative new human signalling proteins revealed by EST data mining

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901642-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901642-1

1 reference

7 January 2021

The use of single-nucleotide polymorphism maps in pharmacogenomics

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901642-1

7 January 2021

The Human Genome Project--an overview

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901642-1

7 January 2021

… as consortium plans free SNP map of human genome

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901642-1

7 January 2021

Linkage disequilibrium mapping of complex disease: fantasy or reality?

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901642-1

7 January 2021

How many diseases does it take to map a gene with SNPs?

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901642-1

7 January 2021

Y chromosome sequence variation and the history of human populations

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901642-1

7 January 2021

Population genetics--making sense out of sequence

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901642-1

7 January 2021

History of drugs for thrombotic disease. Discovery, development, and directions for the future

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901642-1

7 January 2021

Drug discovery and development in the molecular era.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901642-1

7 January 2021

Populations and genetic polymorphisms

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901642-1

7 January 2021

Population studies of polymorphisms at loci of neuropsychiatric interest (tryptophan hydroxylase (TPH), dopamine transporter protein (SLC6A3), D3 dopamine receptor (DRD3), apolipoprotein E (APOE), mu opioid receptor (OPRM1), and ciliary neurotrophic

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901642-1

7 January 2021

Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901642-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901642-1

1 reference

7 January 2021

Can pharmacogenomics make a difference in drug development?

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901642-1

7 January 2021

Clinical trials in pharmacogenetics and pharmacogenomics: methods and applications

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901642-1

7 January 2021

Pharmacogenetics and future drug development and delivery

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901642-1

7 January 2021

Pharmacogenetics and the practice of medicine

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901642-1

7 January 2021

A SNPshot: pharmacogenetics and the future of drug therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901642-1

7 January 2021

Pharmacogenomics: translating functional genomics into rational therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901642-1

7 January 2021

Molecular characterisation of two cell lines selected for resistance to the folate-based thymidylate synthase inhibitor, ZD1694.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901642-1

7 January 2021

Pharmacogenetics as a molecular basis for individualized drug therapy: the thiopurine S-methyltransferase paradigm

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901642-1

7 January 2021

Ethical and legal issues in the procurement, storage and use of DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901642-1

7 January 2021

Antiepileptic drug pharmacogenetics

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901642-1

7 January 2021

Pharmacogenetics and psychopharmacotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901642-1

7 January 2021

Prospects for whole-genome linkage disequilibrium mapping of common disease genes

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901642-1

7 January 2021

Genetics of complex disease: approaches, problems, and solutions

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901642-1

7 January 2021

Carrier detection of Batten disease (Juvenile neuronal ceroid-lipofuscinosis)

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901642-1

7 January 2021

Hemochromatosis: a genetic defect in iron metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901642-1

7 January 2021

10.1016/S1359-6446(00)01642-1

Identifiers

DOI

1 reference

23 September 2017

1 reference